Where you inject matters: new study tests KAI-9531 in arm, thigh, and belly
NCT ID NCT07044401
First seen Dec 16, 2025 · Last updated May 14, 2026 · Updated 17 times
Summary
This study looked at how the injection site (upper arm, thigh, or abdomen) affects the absorption of a drug called KAI-9531 in healthy volunteers with different body weights. 51 participants each received a single injection in different spots to compare drug levels in the blood. The goal was to understand the best injection location for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.